Navigation Links
Pioneer in neural development honored with the Mortimer D. Sackler, M.D. Prize
Date:2/19/2013

NEW YORK, NY (February 19, 2013) Columbia University College of Physicians and Surgeons and Weill Cornell Medical College have announced that the Mortimer D. Sackler, M.D. Prize for Distinguished Achievement in Developmental Psychobiology has been awarded to Carla Shatz, PhD, the Sapp Family Provostial Professor in Neurobiology at Stanford University in Palo Alto, California. Dr. Shatz's work has advanced understanding of fundamental principles of early brain development with the discovery that neuronal activity prior to birth is essential for later formation and refinement of connections in the visual system. Her work has important implications for understanding how the visual system refines its connectionswork that has contributed to our understanding of critical periods of brain wiring in developmental disorders such as autism and schizophrenia.

Dr. Shatz's selection as this year's Sackler Prize recipient is in recognition not only of her pioneering achievements in the understanding of early brain development, but also of her leadership in the field of neuroscience and her track record of mentorship.

"Dr. Shatz has provided some of our most profound insights into the way the brain matures during early life, including the importance of neural activity in shaping development. Her work provides a blueprint for understanding how brain function is molded at very young ages. She is a wonderful pick for the prize that commemorates Dr. Mortimer D. Sackler's legacy and his passion for understanding the biological basis of neuropsychiatric disorders," said Jay Gingrich, MD, PhD, director of the Columbia Sackler Institute and the Sackler Institute Professor of Developmental Psychobiology at Columbia University Medical Center and the New York State Psychiatric Institute.

"I am thrilled about this year's recipient of the prize. Not only has Dr. Shatz provided new insights into early brain development that have important implications for neurodevelopmental disorders, she has been a world-class leader in integrating a multitude of disciplines necessary for understanding the complexities of the human brain. This interdisciplinary approach to bridging disparate scientific viewswith unusual harmonyis a philosophy shared across the Sackler Institutes, as part of Dr. Sackler's vision," said B.J. Casey, PhD, director of the Sackler Institute and the Sackler Professor of Developmental Psychobiology at Weill Cornell Medical College.

The Sackler Prize is selected by a committee of 15, including faculty from each of the six Sackler Institutes, programs, and centers: Weill Cornell Medical College; Columbia University Medical Center; Universities of Edinburgh, Glasgow; University of Sussex; King's College London; and McGill University. Dr. Shatz will hold grand rounds at Columbia and Weill Cornell at the end of February and the beginning of March.

Dr. Shatz said, "I am thrilled and honored to receive this wonderful recognition from the Sackler Institutes in the name of this distinguished family. Understanding fundamental mechanisms of brain development and the dynamic interplay between nature and nurture are essential for treating, and someday curing, neurodevelopmental disorders such as autism and schizophrenia."

Asked about the most unexpected insight from her own work, she said, "Discovering that nerve cells in the baby's brain spontaneously send signals from the eye to the brain's visual centers long before vision. It is as if the brain is running test patterns and rehearsing for vision long before birth, and we know that this rehearsal is a key part of brain-circuit tuning during development."

Dr. Shatz is director of Bio-X, Stanford University's pioneering interdisciplinary biosciences program that brings together faculty from across the entire universityclinicians, biologists, engineers, physicists, and computer scientiststo unlock the secrets of the human body in health and disease.

In 1976, Dr. Shatz was the first woman to earn a PhD in neurobiology at Harvard Medical School, where she studied with Nobel laureates David Hubel and Torsten Wiesel. In 1978, she joined the faculty as assistant professor of neurobiology at Stanford, where she was the first woman to receive tenure in the basic sciences.

Dr. Shatz is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, the American Philosophical Society, and the Institute of Medicine and was recently elected as a Foreign Member of the Royal Society of London. She has been a Howard Hughes investigator and received numerous awards, including the Gill Prize in Neuroscience, the Society for Neuroscience's Salpeter Lifetime achievement award, and the Ralph Gerard Prize in Neuroscience.

The Mortimer D. Sackler, M.D. Prize for Distinguished Achievement in Developmental Psychobiology

The Mortimer D. Sackler, M.D. Prize for Distinguished Achievement in Developmental Psychobiology recognizes researchers who have advanced our understanding of the developmental processes of mind, brain, and behavior that contribute to normal development and of the origins of mental illness. The prize aims to foster international cooperation among scientists and promote public understanding of their work. The prize is presented jointly every two years by the Sackler Institute for Developmental Psychobiology at Columbia University College of Physicians and Surgeons and the Sackler Institute for Developmental Psychobiology at Weill Cornell Medical College. The first prize was awarded in 2008 to Dr. Avshalom Caspi of King's College, London, and Duke University. Dr. Fernando Nottebohm of the Rockefeller University received the prize in 2010.

The prize honors one of the most creative scientists in the field of developmental psychobiology, the late Mortimer D. Sackler, M.D., who began his career as a psychiatrist and pioneer researcher in biological psychiatry in the late 1940s at the New York State Department of Mental Health. During this early period, he published more than 40 papers in peer-reviewed journals, which highlighted the role of early childhood development in later psychiatric illness. In the early 1950s, Dr. Sackler, with his brothers, founded the pharmaceutical company known today as Purdue Pharma. The original prize was a gift in honor of Dr. Sackler's 90th birthday from his seven children, and the prize was endowed in 2009 by a gift from The Mortimer D. Sackler Foundation, Inc.

The Sackler Institutes at Weill Cornell Medical College and Columbia University Medical Center

The Sackler Institute for Developmental Psychobiology was endowed and established at Columbia University Medical Center in 2000 by the Sackler FoundationLa Fondation Sackler and is dedicated to research into the complex processes underlying normal development as well as the origins of psychiatric illness, working at levels ranging from the molecular to the psychological.

The Sackler Institute for Developmental Psychobiology at Weill Cornell Medical College, established and endowed in 1996 by the Sackler FoundationLa Fondation Sackler and Mortimer D. Sackler, M.D., family members and related entities, is focused on research and training using state-of-the-art brain-imaging techniques, human and mouse genetics, and novel behavioral methods to study typical and atypical human brain development.


'/>"/>

Contact: Karin Eskenazi
ket2116@columbia.edu
212-342-0508
Columbia University Medical Center
Source:Eurekalert

Related biology news :

1. Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research
2. UCSB researchers perform pioneering research on Type 2 diabetes
3. Pioneering researcher receives Heart Association Lifetime Achievement Award
4. Stanford bioengineer Christina Smolke wins NIH Directors Pioneer Award
5. 2 pioneering plant genomics efforts given a funding boost by National Science Foundation
6. Project MICREAgents: Self-assembling smart microscopic reagents to pioneer pourable electronics
7. Pioneering self-contained smart village offers world model for rural poverty relief
8. BGI, GE Healthcare team up on pioneering stem cell science projects
9. Good news for nanomedicine: Quantum dots appear safe in pioneering study on primates
10. March of Dimes awards $250,000 prize to 2 scientists who pioneered advances in skin disorders
11. Space research institute honors Sen. Hutchison with Pioneer Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
(Date:6/2/2016)... YORK , June 2, 2016   The Weather ... is announcing Watson Ads, an industry-first capability in which consumers ... by being able to ask questions via voice or text ... Marketers have long sought ... the consumer, that can be personal, relevant and valuable; and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... quality, regulatory and technical consulting, provides a free webinar on Performing ... July 13, 2016 at 12pm CT at no charge. , Incomplete investigations are ...
Breaking Biology Technology: